Showing results (2251-2260 of 2,945) with videos related to

Sort By:
Pageof 295
International Journal of Pharmaceutics|March 6, 2019
A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulationsYimei Jia, Bassel Akache, Lise Deschatelets, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
Plos One|December 5, 2018
Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in miceBassel Akache, Felicity C Stark, Yimei Jia, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 2, 2003
A new Pan African polyspecific antivenom developed in response to the antivenom crisis in AfricaG D Laing, J M Renjifo, F Ruiz, et al.
Pediatric Emergency Care|October 18, 2016
Association of Delay in Appendectomy With Perforation in Children With AppendicitisJames A Meltzer, Sergey Kunkov, Jennifer H Chao, et al.
Biological Psychiatry|July 18, 2015
Jumping the Gun: Mapping Neural Correlates of Waiting Impulsivity and Relevance Across Alcohol MisuseLaurel S Morris, Prantik Kundu, Kwangyeol Baek, et al.
Foodborne Pathogens and Disease|March 11, 2009
Genotyping Campylobacter jejuni by comparative genome indexing: an evaluation with pulsed-field gel electrophoresis and flaA SVR sequencingLauren G Pittenger, Mark D Englen, Craig T Parker, et al.
Journal of Food Protection|March 8, 2011
Effects of sodium citrate plus sodium diacetate and buffered vinegar on Escherichia coli O157:H7 and psychrotrophic bacteria in brine-injected beefAmudhan Ponrajan, Mark A Harrison, Jacob R Segers, et al.
Cancer Medicine|November 10, 2021
Aggressiveness of care at end of life in patients with high-grade gliomaRebecca A Harrison, Alexander Ou, Syed M A A Naqvi, et al.
Heart (British Cardiac Society)|August 2, 2020
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million peopleJulia Hippisley-Cox, Duncan Young, Carol Coupland, et al.
Pageof 295